TCT-765 Effect of PSP and other Elements of Technique on 3 Year Outcomes Among Metallic Everolimus-Eluting Stent-Treated Patients in the ABSORB Trials

Stephen G. Ellis; Dean J. Kereiakes; Patrick W. Serruys; Yoshinobu Onuma; Takeshi Kimura; Runlin Gao; Ovidiu Dressler; Thomas McAndrew; Gregg W. Stone

doi:10.1016/j.jacc.2018.08.1993

Related publications

Article2013

TCT-36 One-year Clinical Outcomes of Diabetic Patients Treated With Everolimus-Eluting Bioresorbable Vascular Scaffolds: A Pooled Analysis From the ABSORB Cohort B and the ABSORB EXTEND Trials.

Takashi Muramatsu, Yoshinobu Onuma, Robert J. Van Geuns, Bernard Chevalier, Tejas Patel, Ashok Seth, Roberto Diletti, Héctor M. García‐García, Cécile Dorange, Susan Veldhof, Wai‐Fung Cheong, Robert Whitbourn, Antonio L. Bartorelli, Alexandre Abizaid, Patrick W. Serruys

Journal of the American College of Cardiology

Letter2018

The Long-Term Impact of Post-Procedural Asymmetry and Eccentricity of Bioresorbable Everolimus-Eluting Scaffold and Metallic Everolimus-Eluting Stent on Clinical Outcomes in the ABSORB II Trial

Yuki Katagiri, Patrick W. Serruys, Carlos Macaya, John A. Ormiston, Jonathan Hill, Iréne Lang, Mohaned Egred, Jean Fajadet, Maciej Lesiak, Joanna J. Wykrzykowska, Jan J. Piek, Manel Sabaté, Stephan Windecker, Bernard Chevalier, Yoshinobu Onuma

КАРДИОЛОГИЯ УЗБЕКИСТАНА

Article2020

Bioresorbable scaffolds versus everolimus-eluting metallic stents: five-year clinical outcomes of the randomised ABSORB II trial

Yoshinobu Onuma, Bernard Chevalier, Masafumi Ono, Ángel Cequier, Dariusz Dudek, Michael Haude, Didier Carrié, Manel Sabaté, Stephan Windecker, Richard Rapoza, Nick E.J. West, Sebastian Reith, Manuel de Sousa Almeida, Gianluca Campo, Andrés Íñiguez, Patrick W. Serruys

EuroIntervention

Article2018

TCT-62 Five-Year Clinical Outcomes With Everolimus-Eluting Bioresorbable Scaffolds: Results From the Randomized ABSORB II Trial

Patrick W. Serruys, Bernard Chevalier

Journal of the American College of Cardiology

Article2014

TCT-619 ABSORB Cohort B Trial: Five Year Angiographic Results Of The ABSORB Everolimus Eluting Bioresorbable Vascular Scaffold

Bernard De Bruyne, Gábor G. Tóth, Yoshinobu Onuma, Patrick W. Serruys

Journal of the American College of Cardiology

TCT-765 Effect of PSP and other Elements of Technique on 3 Year Outcomes Among Metallic Everolimus-Eluting Stent-Treated Patients in the ABSORB Trials

Abstract

Discussion(0)

Related publications

TCT-36 One-year Clinical Outcomes of Diabetic Patients Treated With Everolimus-Eluting Bioresorbable Vascular Scaffolds: A Pooled Analysis From the ABSORB Cohort B and the ABSORB EXTEND Trials.

The Long-Term Impact of Post-Procedural Asymmetry and Eccentricity of Bioresorbable Everolimus-Eluting Scaffold and Metallic Everolimus-Eluting Stent on Clinical Outcomes in the ABSORB II Trial

Bioresorbable scaffolds versus everolimus-eluting metallic stents: five-year clinical outcomes of the randomised ABSORB II trial

TCT-62 Five-Year Clinical Outcomes With Everolimus-Eluting Bioresorbable Scaffolds: Results From the Randomized ABSORB II Trial

TCT-619 ABSORB Cohort B Trial: Five Year Angiographic Results Of The ABSORB Everolimus Eluting Bioresorbable Vascular Scaffold